Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 22 of 22 entries
View as:

Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00263640 Org: User:
Start: 05/31/05 End: 08/31/12 Due: 08/31/13

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Phase: N/A Priority: Normal
NCT ID: NCT00666341 Org: User:
Start: 09/30/07 End: 05/31/10 Due: 05/31/11

Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT02297490 Org: User:
Start: 01/31/14 End: 12/31/14 Due: 12/31/15

Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT00309062 Org: User:
Start: 12/31/03 End: 06/30/09 Due: 06/30/10

Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT00263549 Org: User:
Start: 09/30/02 End: 02/28/06 Due: 02/28/07

Multicenter Trial of Immunotherapy With House Dust Mite Allergoid

Phase: N/A Priority: Normal
NCT ID: NCT00540631 Org: User:
Start: 10/31/07 End: 12/31/11 Due: 12/31/12

Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children

Phase: N/A Priority: Normal
NCT ID: NCT00841256 Org: User:
Start: 02/29/08 End: 08/31/15 Due: 08/31/16

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT00263601 Org: User:
Start: 11/30/01 End: 08/31/10 Due: 08/31/11

2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01353755 Org: User:
Start: 10/31/09 End: 09/30/14 Due: 09/30/15

Efficacy and Safety of a Purified Standardised Wasp Venom Preparation

Phase: N/A Priority: Normal
NCT ID: NCT00263926 Org: User:
Start: 03/31/01 End: 11/30/10 Due: 11/30/11

Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative

Phase: N/A Priority: Normal
NCT ID: NCT00841516 Org: User:
Start: 12/31/07 End: 05/31/13 Due: 05/31/14

Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation

Phase: N/A Priority: Normal
NCT ID: NCT00623701 Org: User:
Start: 03/31/08 End: 10/31/12 Due: 10/31/13

Efficacy and Safety of a Purified Standardised Bee Venom Preparation

Phase: N/A Priority: Normal
NCT ID: NCT00263952 Org: User:
Start: 03/31/03 End: 04/30/10 Due: 04/30/11

Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.

Phase: N/A Priority: Normal
NCT ID: NCT00665483 Org: User:
Start: 03/31/07 End: 11/30/10 Due: 11/30/11

Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens

Phase: N/A Priority: Normal
NCT ID: NCT00263627 Org: User:
Start: 06/30/05 End: 03/31/10 Due: 03/31/11

Efficacy and Safety From a Recombinant Folding Variant of Bet v 1

Phase: N/A Priority: Normal
NCT ID: NCT00554983 Org: User:
Start: 09/30/07 End: 05/31/12 Due: 05/31/13

Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT01490411 Org: User:
Start: 10/31/10 End: 09/30/11 Due: 09/30/12

Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV

Phase: N/A Priority: Normal
NCT ID: NCT00266526 Org: User:
Start: 07/31/03 End: 07/31/05 Due: 07/31/06

Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00671268 Org: User:
Start: 03/31/08 End: 03/31/13 Due: 03/31/14

Open Label Safety Study of a Birch Pollen Allergen Extract

Phase: N/A Priority: Normal
NCT ID: NCT00818181 Org: User:
Start: 06/30/08 End: 08/31/10 Due: 08/31/11

Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture

Phase: N/A Priority: Normal
NCT ID: NCT00264459 Org: User:
Start: 02/28/03 End: 09/30/11 Due: 09/30/12

Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT00309036 Org: User:
Start: 01/31/04 End: 05/31/08 Due: 05/31/09